Funds will Support Creation of Life-Saving Pediatric Fluid Management Product EDEN PRAIRIE, Minn. , Aug. 05, 2021 (GLOBE NEWSWIRE) -- Critically-ill children and babies with kidney failure or who are dependent on artificial kidney support currently do not have enough therapeutic options.

EDEN PRAIRIE, Minn. , July 27, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), announced today that its second quarter 2021 financial results will be released on Tuesday, August 10, 2021. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss

The newly classified code expands access to life-saving, novel fluid removal technology EDEN PRAIRIE, Minn. , July 13, 2021 (GLOBE NEWSWIRE) -- In an effort to increase the availability of life-saving ultrafiltration therapy to people experiencing fluid overload, the American Medical Association

EDEN PRAIRIE, Minn. , July 06, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, today announced that, Nestor Jaramillo , Chief Executive officer, and George Montague , Chief Financial Officer, are scheduled

EDEN PRAIRIE, Minn. , June 24, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective June 22, 2021 , the independent directors approved four equity awards under Nuwellis’ 2021 Inducement Plan, as material inducement to four individuals entering into employment with

George Montague to serve as Chief Financial Officer and Neil P. Ayotte, to serve as General Counsel and Chief Compliance Officer EDEN PRAIRIE, Minn. , June 22, 2021 (GLOBE NEWSWIRE) -- Continuing its dynamic growth in support of its commitment to expanding access to life-saving ultrafiltration

Leading group purchasing organization will utilize relationships to consolidate costs and expand nationwide reach of the Aquadex SmartFlow® System EDEN PRAIRIE, Minn. , June 01, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), formerly CHF Solutions, Inc.

EDEN PRAIRIE, Minn. , May 20, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective May 19, 2021 , the independent directors approved eight equity awards under Nuwellis’ 2021 Inducement Plan, as material inducement to an individual entering into employment with the

Treatment with Aquadex therapy showed significant weight decrease, clinical symptom improvement and decreased readmissions among heart failure patients. EDEN PRAIRIE, Minn. , May 17, 2021 (GLOBE NEWSWIRE) -- Data supporting the effectiveness of Aquadex FlexFlow ® system in the treatment of acutely

Gentle Ultrafiltration with Aquadex SmartFlow® Expands Options for Pediatric Patients EDEN PRAIRIE, Minn. , May 13, 2021 (GLOBE NEWSWIRE) -- Reaffirming its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload,